基于五位一体的药品安全社会共治格局建设思考  

Considerations on the 5-in-1 social co-governance for drug safety

作　　者：赵允伍 王珩[1] 吴静雅[1] 卞城 李念念[2] 

机构地区：[1]安徽医科大学卫生管理学院,合肥230032 [2]安徽医科大学第一附属医院科研处

出　　处：《中华医院管理杂志》2015年第1期39-41,共3页Chinese Journal of Hospital Administration

基　　金：安徽省高等学校2013年度省级自然科学研究重点项目（KJ2013A162）

摘　　要：从药品安全现状的不容乐观性，政府治理的局限性以及社会共治的优势性三方面提出构建以政府、企业、行业协会、媒体及公众为参与主体的、联合联动的“五位一体”药品安全社会共治格局的必要性，分析了基于社会共治格局视角下的药品安全治理的现实困境，提出通过完善法律和制度体系，改革治理权力配置机制，完善社会治理驱动机制，创新治理手段、提高治理能力等措施加强“五位一体”药品安全社会共治格局建设。In this consideration, the paper described the imperatives of drug safety, constraints of governance by the government, and advantages of social co-governance, proposing the necessity to establish a ＂ Five-in-One＂ （referring to the involvement of the government, enterprises, industry associations, media and the public） drug safety social co-governance. In its analysis of the present dilemma of drug safety governance, the authors proposed such measures as perfecting legal and institutional system, reforming governmental power allocation mechanism, improving the incentive mechanism, innovating governance means and improving social governance ability, for the purpose of enhancing such a co-governance pattern.

关 键 词：五位一体 药品安全 社会共治 现实困境 

分 类 号：R95[医药卫生—药学]